{"slideshow_credits": null, "snippet": "With its best-selling drugs losing patent protection, Pfizer is shedding money-making but noncore businesses to focus on pharmaceutical sciences.", "abstract": "Pfizer reports 19 percent profit decline, largely due to loss of sales of Lipitor, its best-selling drug, which lost patent protection in 2011; company reports earnings of $1.79 billion last quarter, or 24 cents a share, compared to $2.22 billion, or 28 cents a share over the same period last year. Photos (M)a", "section_name": "Business; Health; Technology", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS"}, "web_url": "http://www.nytimes.com/2012/05/02/business/pfizer-profit-declines-19-after-loss-of-lipitor-patent.html", "lead_paragraph": "For years, drug companies have known that their days of plenty were numbered, that the moment would arrive when the best-selling drugs that had driven two decades' worth of profits would lose their patent protection and succumb to competition from generic alternatives. Without new blockbusters to replace them, profits would tumble. For Pfizer, that day has arrived. Pfizer profited from hits like Lipitor and Viagra, and swallowed up smaller companies from the 1990s onward.", "headline": {"main": "Pfizer Profit Declines 19% On Slumping Lipitor Sales"}, "_id": "4fd299838eb7c8105d8775e2", "word_count": 1179, "multimedia": [{"height": 75, "url": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/05/02/business/JP-PFIZER-2/JP-PFIZER-2-thumbStandard.jpg", "hasthumbnail": "Y", "thumbnailwidth": 75, "thumbnailheight": 75}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-05-01T00:00:00Z", "source": "The New York Times", "news_desk": "Business Day", "keywords": [{"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "LIPITOR (DRUG)"}, {"name": "subject", "value": "COMPANY REPORTS"}, {"name": "subject", "value": "INVENTIONS AND PATENTS"}], "blog": [], "subsection_name": null, "type_of_material": "News"}